Workflow
BRBR SECURITIES ALERT: BellRing Brands 18% Stock Drop Triggers Securities Class Action Investigation – Investors Notified to Contact BFA Law
Globenewswire· 2025-11-07 21:34
NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing Being Investigated? BellRing Brands operates in the convenient nutrition category. The Compa ...
Wendy's is still losing to rivals like McDonald's, but not by as much as feared
MarketWatch· 2025-11-07 21:34
The results came as Wendy's has been aggressively working to turn things around. ...
The Hain Celestial Group, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:HAIN) 2025-11-07
Seeking Alpha· 2025-11-07 21:33
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
BioHarvest Sciences to raise $17.4M in upsized public equity offering
Proactiveinvestors NA· 2025-11-07 21:33
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
NanoViricides' NV-387 shows broad antiviral potential, says Zacks
Proactiveinvestors NA· 2025-11-07 21:33
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Next Hydrogen Announces $20 to $30M Equity Private Placement led by Smoothwater Capital Corporation
Globenewswire· 2025-11-07 21:33
MISSISSAUGA, Ontario, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen”) (TSXV:NXH, OTC:NXHSF), a Canadian designer and manufacturer of hydrogen electrolyzers, is pleased to announce its intention to complete a non-brokered private placement of common shares at a price of CAD$0.45 per share (the “Offering Price”) with minimum gross proceeds of CAD$20,000,000 and maximum of CAD$30,000,000, or such other maximum amount as the Company may determine (the “Offering” ...
The Chemours Company 2025 Q3 - Results - Earnings Call Presentation (NYSE:CC) 2025-11-07
Seeking Alpha· 2025-11-07 21:32
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Newmont cuts 16% of workforce in restructuring after Newcrest deal- memo
Reuters· 2025-11-07 21:32
Newmont has cut about 16% of its workforce as part of a restructuring following the acquisition of Australian miner Newcrest, according to an internal memo to staff seen by Reuters. ...
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
Prnewswire· 2025-11-07 21:31
Accessibility StatementSkip Navigation Oral GPR119 Agonist Demonstrated Clinically Meaningful Reductions in HbA1c, Improvements in Liver Inflammation and Fibrosis, and Favorable Changes in Plasma Lipidomic Profiles CAMBRIDGE, Mass., Nov. 7, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of positive new data from its Phase 2a clinical trial evaluating vanoglipel (DA-1241), a potent an ...
Microsoft: Why Investors Shouldn’t Fear the Dip in Stock
Investing· 2025-11-07 21:31
Market Analysis by covering: Microsoft Corporation. Read 's Market Analysis on Investing.com ...